TWO SIGMA ADVISERS, LP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$875,996
-64.4%
8,600
-64.8%
0.00%
-66.7%
Q2 2023$2,462,204
-95.0%
24,400
-95.4%
0.01%
-95.2%
Q1 2023$48,980,800
-66.4%
532,400
-66.9%
0.13%
-69.0%
Q4 2022$145,741,680
-17.9%
1,606,500
-31.2%
0.41%
-20.8%
Q3 2022$177,544,000
-18.4%
2,335,800
-9.2%
0.51%
-16.7%
Q2 2022$217,513,000
-15.6%
2,573,200
-12.4%
0.62%
-9.9%
Q1 2022$257,695,000
+2.7%
2,936,700
+2.3%
0.68%
+8.9%
Q4 2021$251,013,000
+46.4%
2,869,700
+36.9%
0.63%
+41.7%
Q3 2021$171,476,000
-0.7%
2,096,800
+10.8%
0.44%
-2.6%
Q2 2021$172,726,000
+5231.0%
1,893,100
+4717.0%
0.46%
+3700.0%
Q1 2020$3,240,000
-29.3%
39,300
-25.4%
0.01%
+9.1%
Q3 2019$4,580,000
+416.9%
52,700
+443.3%
0.01%
+450.0%
Q2 2019$886,000
+77.2%
9,700
+67.2%
0.00%
+100.0%
Q3 2018$500,000
-96.5%
5,800
-96.9%
0.00%
-97.4%
Q2 2018$14,202,000
+674.0%
188,000
+728.2%
0.04%
+660.0%
Q1 2018$1,835,000
+270.7%
22,700
+233.8%
0.01%
+150.0%
Q4 2016$495,000
+102.0%
6,800
+173.4%
0.00%0.0%
Q2 2015$245,000
-35.0%
2,487
-37.8%
0.00%
-33.3%
Q3 2014$377,000
-20.0%
4,000
-23.1%
0.00%
-25.0%
Q2 2014$471,000
+10.8%
5,200
+4.0%
0.00%0.0%
Q1 2014$425,000
-94.6%
5,000
-95.5%
0.00%
-96.4%
Q2 2013$7,847,000110,9780.11%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders